| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/11/2007 | EP1804793A2 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists |
| 07/11/2007 | EP1608646B1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1355886B1 Fused heterocyclic compounds |
| 07/11/2007 | EP1248784B1 Condensed azepines as vasopressin agonists |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997640A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 07/11/2007 | CN1995036A Optical purity alpha-substituted 2-methyl-5-nitro imidazole-1-ethanol derivative |
| 07/11/2007 | CN1325497C Pharmaceutically active isoindoline derivs. |
| 07/11/2007 | CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors |
| 07/10/2007 | US7241900 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 07/10/2007 | US7241803 Compounds for inhibition of HIV infection by blocking HIV entry |
| 07/10/2007 | US7241794 Nonnucleoside reverse transcriptase inhibitors |
| 07/10/2007 | US7241786 Compounds inhibit A beta -peptide production; may be used for treatment of Alzheimer's disease and other neurological disorders in mammals, including humans |
| 07/10/2007 | US7241785 Five-membered heterocyclic alkanoic acid derivative |
| 07/10/2007 | US7241784 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 07/10/2007 | US7241780 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 07/10/2007 | US7241772 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity |
| 07/10/2007 | US7241761 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups |
| 07/10/2007 | US7241760 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241745 Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives |
| 07/05/2007 | WO2007076474A1 Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases |
| 07/05/2007 | WO2007076473A2 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases |
| 07/05/2007 | WO2007076460A2 Substituted thiazole ureas useful as inhibitors of protein kinases |
| 07/05/2007 | WO2007076431A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/05/2007 | WO2007076104A1 Vanilloid receptor ligands and their use in treatments |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074893A1 Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative |
| 07/05/2007 | WO2007074786A1 Probe for diagnosis of conformational disease |
| 07/05/2007 | WO2007073698A1 2,2',6,6'-tetraoxazoline ligands with a biphenyl backbone and their preparation methods |
| 07/05/2007 | WO2007058602A3 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
| 07/05/2007 | WO2007047496A3 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/05/2007 | WO2006067466A3 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 07/05/2007 | US20070155966 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV) |
| 07/05/2007 | US20070155810 Enzyme inhibitors as bactericides for infections and enzyme inhibitors |
| 07/05/2007 | US20070155798 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes torezolid phosphate |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155792 Enzyme inhibitors as bactericides for infections and as enzyme inhibitors |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155789 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 07/05/2007 | US20070155763 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155746 Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases |
| 07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 07/05/2007 | US20070155744 N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors |
| 07/05/2007 | US20070155743 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders |
| 07/05/2007 | US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression |
| 07/05/2007 | US20070155739 Substituted bis-amide metalloprotease inhibitors |
| 07/05/2007 | US20070155733 1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidone hydrochloride; useful in reversing multidrug resistance |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155724 Methods of Treating Cytokine Mediated Diseases |
| 07/05/2007 | US20070155722 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms |
| 07/05/2007 | US20070155721 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide |
| 07/05/2007 | US20070155717 Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 07/05/2007 | US20070155701 Keto cannabinoids with therapeutic indications |
| 07/05/2007 | US20070154980 Fluorescent dyes |
| 07/05/2007 | CA2634794A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/05/2007 | CA2634198A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/05/2007 | CA2633367A1 Aryl-isoxazol-4-yl-imidazole derivatives |
| 07/05/2007 | CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | CA2631777A1 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor |
| 07/05/2007 | CA2626839A1 5-aryl isoxazolines for controlling invertebrate pests |
| 07/04/2007 | EP1803716A1 A process for preparation of racemic nebivolol |
| 07/04/2007 | EP1803715A1 A process for preparation of racemic nebivolol |
| 07/04/2007 | EP1802615A1 Phosphodiesterase 4 inhibitors |
| 07/04/2007 | EP1802613A1 Substituted oxazolidinone derivatives |
| 07/04/2007 | EP1802609A2 Thrombin receptor antagonists |
| 07/04/2007 | EP1802594A1 Novel oxadiazinone derivatives and use thereof as ppar-alpha modulators |
| 07/04/2007 | EP1802588A1 Substituted amino-pyrimidones and uses thereof |
| 07/04/2007 | EP1802585A1 4-substituted 4,6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 07/04/2007 | EP1802311A1 4-aminophenyl morpholinone derivatives for the treatment of hepatitis c |
| 07/04/2007 | EP1622896B1 Novel aniline derivatives, their manufacture and use as pharmaceutical agents |
| 07/04/2007 | EP1260512B1 Novel cyclic amide derivatives |
| 07/04/2007 | CN1993359A Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 07/04/2007 | CN1993352A Piperazine derivatives with CCR3 inhibiting activity |
| 07/04/2007 | CN1993349A Quinazoline derivatives as ERBB receptor tyrosine kinases |
| 07/04/2007 | CN1993331A N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 07/04/2007 | CN1993319A Benzyloxy derivatives as MAOB inhibitors |
| 07/04/2007 | CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor |
| 07/04/2007 | CN1990471A Mch antagonists and their use in the treatment of obesity |
| 07/04/2007 | CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1324017C Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives |
| 07/04/2007 | CN1324001C Novel thyroid receptor ligands |
| 07/03/2007 | US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238724 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 07/03/2007 | US7238721 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/03/2007 | US7238720 Pharmaceutical use of N-carbamoylazole derivatives |
| 07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 07/03/2007 | US7238716 Alkanoic acid derivatives process for their production and use thereof |
| 07/03/2007 | US7238713 Muscarinic agonists |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238697 Insecticides for crops |
| 07/03/2007 | US7238695 Imidazolyl derivatives |